Dr. Antin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
# Dana-Far
Boston, MA 02115Phone+1 617-632-3667Fax+1 617-632-5175
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1981 - 1983
- Brigham and Women's HospitalResidency, Internal Medicine, 1978 - 1981
- Weill Cornell MedicineClass of 1978
Certifications & Licensure
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Boston Herald Castle Connolly, 2005
- Join now to see all
Clinical Trials
- Blood and Marrow Transplant Clinical Research Network Start of enrollment: 2001 Sep 01
- Phase I Study of Sequential Cord Blood Transplants Start of enrollment: 2003 May 01
- Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 158 citationsImpact of Conditioning Regimen Intensity on Outcome of Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Myelogenous Leukemia and Myelodysplastic SyndromeEdwin P. Alyea, Haesook T. Kim, Vincent T. Ho, Corey Cutler, Daniel J. DeAngelo
Biology of Blood and Marrow Transplantation. 2006-10-01 - 198 citationsAutologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CT...Amrita Krishnan, Marcelo C. Pasquini, Brent R. Logan, Edward A. Stadtmauer, David H. Vesole
The Lancet. Oncology. 2011-12-01 - 43 citationsBlood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Pr...Marcelo C. Pasquini, Brent R. Logan, Richard J. Jones, Amin M. Alousi, Frederick R. Appelbaum
Biology of Blood and Marrow Transplantation. 2018-06-01
Journal Articles
- Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host DiseaseJoseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood
Abstracts/Posters
- Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...Joseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host DiseaseJoseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Pr...Joseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- ASBMT NewsOctober 13th, 2018
- Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 9th, 2017
- Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 8th, 2017
- Join now to see all
Grant Support
- A Randomized Trial Of Tac/Mtx/Bortezomib VS Tac/Mtxplacebo In Allogeneic HSCTNational Heart, Lung, And Blood Institute2011
- Novel Approaches To Graft-Versus-Host Disease PreventionNational Cancer Institute2009–2011
- Mechanisms Of GVHDNational Cancer Institute2009–2011
- Administrative CoreNational Cancer Institute2009–2011
- Random Trial Of CD8 T-Cell Depletion In PBSC TransplantationNational Heart, Lung, And Blood Institute2006–2010
- Novel Approaches To Ghvd PreventionNational Heart, Lung, And Blood Institute2007
- Mechanisms Of GVHDNational Heart, Lung, And Blood Institute2003–2007
- Randomized Trial Of CD8 T-Cell Depletion In PBSC Transp*National Heart, Lung, And Blood Institute2001–2005
- Use Of Unrelated Donors For Bone Marrow TransplantationNational Center For Research Resources1997–1999
- Phlebotomy For Research Studies After Marrow TransplantationNational Center For Research Resources1997–1999
- Core--Clinical Bone Marrow Transplant ProgramNational Cancer Institute1997
- Novel Therapy For Chronic Myelogenous LeukemiaNational Cancer Institute1993–1996
Professional Memberships
- Member
- American Society of Blood and Marrow TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: